We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| African Pioneer Plc | LSE:ASP | London | Ordinary Share | IM00B8C0HK22 | ORD NPV |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 3.75 | 0.00 | 00:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 3.50 | 4.00 | ||||
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 3.75 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 13/8/2024 | 15:38 | ALNC |  TRADING UPDATES: Safestay expands in Hungary; Light Science wins order |
| 02/5/2024 | 10:10 | ALNC | EARNINGS AND TRADING: Smiths News ups dividend; NAHL profit rises |
| 30/4/2024 | 20:56 | ALNC | EARNINGS: Anglo-Eastern Plantations lifts dividend; profit falls |
| 16/4/2024 | 19:34 | ALNC | EARNINGS AND TRADING: AssetCo deputy retiring, Chapel Down ups revenue |
| 16/2/2024 | 12:32 | ALNC | African Pioneer shares up as First Quantum exercises Zambian licences |
| 07/2/2024 | 14:14 | ALNC | IN BRIEF: African Pioneer says Ongombo licence extended for two years |
African Pioneer (ASP) Share Charts1 Year African Pioneer Chart |
|
1 Month African Pioneer Chart |
Intraday African Pioneer Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 06/5/2016 | 11:05 | Steely Dan | 2 |
| 11/1/2009 | 19:01 | Ascribe .... new to AIM | 280 |
| 01/12/2007 | 21:29 | Ascribe...time to buy??? | - |
| 11/5/2004 | 06:53 | Aspinalls - Shares 0.01p, Cash = 0.025p | 319 |
| 02/1/2003 | 09:52 | ASPINALLS, LOOKING GOOD FOR THE FUTURE | 2,813 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 17/12/2008 09:22 by ltinvestor Having invested in this company 4 years before it came to AIM and at a period when it needed funds I feel very dissapointed that the directors are able to buy the company back for such a low price taking advantage of the present market climate for small stocks. |
Posted at 15/12/2008 11:51 by chrisdgb anyone else have an idea of the bid price?? |
Posted at 12/12/2008 10:37 by chrisdgb price tightening...bid by Christmas..??? add to my Macro 4 present already... |
Posted at 12/11/2008 11:41 by chrisdgb ECI Ventures supposed to be exclusive on the bid, wonder what the price will be, 33p????? |
Posted at 01/10/2008 07:02 by chrisdgb nice looking results this morning, should move through the 30p....apparently management think company is worth 60p per share.... |
Posted at 19/8/2008 16:49 by ltinvestor Any guesses to buyout price?I am holding on as I expect the price to be higher than todays price. |
Posted at 29/5/2008 23:00 by backmarker there was a reasonably positive article on ASP in SHARES mag. today.probably that which helped lift the share price |
Posted at 07/12/2007 13:00 by currypasty RNS Number:4417JAscribe plc 07 December 2007 Ascribe plc (the "Company") Holding in Company The Company received notification on 6 December 2007 from Universities Superannuation Scheme Ltd ("USS") that on 4 December 2007 USS had a notifiable interest in the Company of 3,684,909 ordinary shares of 1p each in the Company, representing 3.14 per cent. of the Company's current issued ordinary share capital. 7 December 2007 |
Posted at 29/11/2007 12:56 by currypasty RNS Number:7729IAscribe plc 29 November 2007 Ascribe plc (the "Company") Director Shareholding in Company The Company was informed on 29 November 2007 that Ian Priestner and David Hughes, both directors of the Company have purchased ordinary shares of 1p each in the Company ("Ordinary Shares"). Ian Priestner purchased 29,972 Ordinary Shares at a price of 33p per share on 28 November 2007. Mr Priestner's interest following this purchase stands at 29,972 Ordinary Shares, which represents 0.026 per cent. of the Company's current issued share capital. David Hughes purchased 65,000 Ordinary Shares at prices between 30 and 30.5p on 28 and 29 November 2007. Mr Hughes's interest following this purchase stands at 415,000 Ordinary Shares, which represents 0.353 per cent. of the Company's current issued share capital |
Posted at 22/10/2007 11:48 by currypasty RNS Number:1231GAscribe plc 22 October 2007 Press Release 22 October 2007 Ascribe plc ("Ascribe" or "the Group") Ascribe plc acquires Scorpio Information Systems Limited enhancing portfolio of healthcare clinical information management systems 22 October 2007 - Ascribe plc (AIM:ASP), the health IT Group, today announces that it has acquired Scorpio Information Systems Limited ("Scorpio"), a supplier of clinical information management systems to the UK National Health Service (" NHS"). Scorpio has developed over thirty clinical modules for hospital departments and patient care; these include endoscopy reporting, maternity, eye-unit casualty and oncology clinics, which are in use at twelve NHS hospitals. This acquisition enables Ascribe to expand its Group offering with a greater range of comprehensive patient-centric information management systems, all of which are capable of securely feeding information into patients' electronic health records. The Ascribe Board expects to cross-sell Scorpio's systems to other customers of the Group. Scorpio will continue to develop clinician-focused modules that address the healthcare IT requirements of modern hospitals. Scorpio's solutions are underpinned by their ability to communicate health data efficiently and their faithful adherence to consistent best practice in a healthcare environment - from data collection through to the establishment of individual patient care pathways. The additional resources of the Ascribe group will enable Scorpio to extend its own suite of healthcare solutions. The total consideration of #1.31m, including payment for approximately #600k cash in Scorpio at completion, was satisfied by the payment of #0.88m cash and by the issue of ordinary shares in Ascribe plc to the value of #0.43m. In its last statutory accounts, Scorpio reported turnover of #0.52m and an operating profit of #0.24m. The Board believes that this acquisition will be earnings enhancing during the first year. Stephen Critchlow, Executive Chairman of Ascribe commented, "I am delighted with this acquisition; Ascribe and Scorpio share a fundamental approach towards product development. We have both focused our software on improving patient safety and supplying robust, integrated systems that quickly and easily deliver the decision critical information required by clinicians. Furthermore, having spent the 16 months since our last purchase developing an integrated business platform into which we can rapidly consolidate future acquisitions, we expect Scorpio to be both earnings enhancing and capable of stimulating further organic growth within a relatively short period." |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
